Hematopoïetic StemCell Transplantation(Pk Med)

N/A

Report date: 2024/03/11 16:39:29

Base Information

Drug NameHematopoïetic StemCell Transplantation(Pk Med)
Drug Alias NamePKM-02
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsHemoglobinopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPk Med SAS
China Registration ClassN/A

Develop Information

Active CompaniesPk Med SAS
Inactive CompaniesN/A
Active IndicationsHemoglobinopathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A